Genomic Test Could Help Predict Aggressive Disease in Men Newly Diagnosed with Prostate Cancer
An analysis of patient data from across Michigan found scores from the Decipher Biopsy test independently aligned with outcomes
Randy Vince, Jr., M.D., M.S.
Newswise After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between taking a watch-and-wait approach, known as active surveillance, or proceeding with surgery or radiation.
And identifying which patients will benefit from more immediate and aggressive treatment isn’t always clear.
A new, University of Michigan-led study analyzing data from more than 850 patients across the state of Michigan, however, found a commercially available genomic test known as Decipher Biopsy may help identify patients who are at high risk of cancer progression.
Genomic test could help predict aggressive disease in men newly diagnosed with prostate cancer
uofmhealth.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uofmhealth.org Daily Mail and Mail on Sunday newspapers.
Genomic test may help identify prostate cancer patients at high risk of disease progression
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.